Canada markets closed

Aileron Therapeutics, Inc. (ALRN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.9500+0.1900 (+5.05%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 65.62M
Enterprise Value 48.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.53
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.18

Trading Information

Stock Price History

Beta (5Y Monthly) 2.24
52-Week Change 3157.76%
S&P500 52-Week Change 324.49%
52 Week High 37.4200
52 Week Low 31.0100
50-Day Moving Average 35.3618
200-Day Moving Average 33.1320

Share Statistics

Avg Vol (3 month) 383.75k
Avg Vol (10 day) 3164.32k
Shares Outstanding 516.87M
Implied Shares Outstanding 616.97M
Float 816.81M
% Held by Insiders 10.16%
% Held by Institutions 114.70%
Shares Short (Apr 15, 2024) 443.41k
Short Ratio (Apr 15, 2024) 41.17
Short % of Float (Apr 15, 2024) 40.27%
Short % of Shares Outstanding (Apr 15, 2024) 40.26%
Shares Short (prior month Mar 15, 2024) 432.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov 11, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.99%
Return on Equity (ttm)-26.91%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.23M
Net Income Avi to Common (ttm)-15.73M
Diluted EPS (ttm)-3.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)17.31M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)48k
Total Debt/Equity (mrq)0.05%
Current Ratio (mrq)4.17
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)-19.81M
Levered Free Cash Flow (ttm)-7.62M